Stay updated on Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.

Latest updates to the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.5.2 was added and v3.5.0 was removed, updating the site version displayed on the page. This change reflects a maintenance update and does not modify trial records or visible content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision indicator updated from v3.4.3 to v3.5.0. This reflects a system update and does not change the study data or page content.SummaryDifference0.0%

- Check42 days agoChange DetectedThe record history now shows the new site revision label v3.4.3 and removes the previous v3.4.2 from the list. This reflects an updated platform version in the record history.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 in the page header/footer.SummaryDifference0.0%

- Check71 days agoChange DetectedAdded Revision: v3.4.1 to the history; removed the government funding lapse notice and the prior v3.4.0 reference.SummaryDifference0.4%

- Check78 days agoChange DetectedAdded a government funding lapse notice at the top of the page informing users that some information may not be up to date and transactions may not be processed. It also directs users to cc.nih.gov and opm.gov for current operating status.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.